Chesley Taft & Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48M | Buy |
3,804
+115
| +3% | +$44.7K | 0.07% | 172 |
|
|
2025
Q1 | $1.6M | Sell |
3,689
-60
| -2% | -$26.1K | 0.08% | 161 |
|
|
2024
Q4 | $1.38M | Hold |
3,749
| – | – | 0.06% | 172 |
|
|
2024
Q3 | $1.95M | Hold |
3,749
| – | – | 0.09% | 145 |
|
|
2024
Q2 | $2.03M | Sell |
3,749
-17
| -0.5% | -$9.21K | 0.1% | 132 |
|
|
2024
Q1 | $1.95M | Hold |
3,766
| – | – | 0.1% | 139 |
|
|
2023
Q4 | $1.78M | Hold |
3,766
| – | – | 0.1% | 138 |
|
|
2023
Q3 | $1.64M | Sell |
3,766
-5
| -0.1% | -$2.18K | 0.11% | 134 |
|
|
2023
Q2 | $1.68M | Sell |
3,771
-70
| -2% | -$31.1K | 0.1% | 141 |
|
|
2023
Q1 | $1.77M | Sell |
3,841
-160
| -4% | -$73.6K | 0.12% | 139 |
|
|
2022
Q4 | $2.05M | Sell |
4,001
-79
| -2% | -$40.5K | 0.14% | 132 |
|
|
2022
Q3 | $1.85M | Sell |
4,080
-35
| -0.9% | -$15.9K | 0.14% | 128 |
|
|
2022
Q2 | $1.99M | Sell |
4,115
-351
| -8% | -$169K | 0.14% | 126 |
|
|
2022
Q1 | $2.28M | Sell |
4,466
-253
| -5% | -$129K | 0.13% | 126 |
|
|
2021
Q4 | $2.19M | Sell |
4,719
-15
| -0.3% | -$6.95K | 0.11% | 133 |
|
|
2021
Q3 | $1.77M | Hold |
4,734
| – | – | 0.1% | 142 |
|
|
2021
Q2 | $1.81M | Sell |
4,734
-20
| -0.4% | -$7.63K | 0.1% | 142 |
|
|
2021
Q1 | $1.69M | Buy |
4,754
+798
| +20% | +$283K | 0.1% | 143 |
|
|
2020
Q4 | $1.27M | Hold |
3,956
| – | – | 0.08% | 152 |
|
|
2020
Q3 | $1.06M | Buy |
3,956
+10
| +0.3% | +$2.69K | 0.08% | 159 |
|
|
2020
Q2 | $1.04M | Buy |
3,946
+131
| +3% | +$34.5K | 0.08% | 157 |
|
|
2020
Q1 | $866K | Sell |
3,815
-15
| -0.4% | -$3.41K | 0.08% | 153 |
|
|
2019
Q4 | $1.16M | Buy |
3,830
+130
| +4% | +$39.3K | 0.08% | 157 |
|
|
2019
Q3 | $888K | Sell |
3,700
-635
| -15% | -$152K | 0.07% | 164 |
|
|
2019
Q2 | $1.22M | Buy |
+4,335
| New | +$1.22M | 0.1% | 140 |
|